Fundai

Tamin Pharmaceutical Investment Company (TIPIKO) income statement

Operating revenue through to net profit and earnings per share

Ticker
TIPIKO
Industry
Pharmaceuticals
Market
Tehran Stock Exchange

Latest periods

Latest 3-month periods, in million rials
ItemTo 1405/05/31To 1404/05/31To 1403/05/31To 1402/05/31To 1401/05/31
سود (زیان) فروش سرمایه گذاری ها153,26415,8622,895,22900
Total operating revenue153,26415,8622,895,229210,273129,874
هزینه های حقوق، دستمزد و مزایا-398,291-308,245-304,893-151,828-83,274
Depreciation expense-7,030-5,429---
Other expenses-83,055-27,472000
جمع هزینه های عملیاتی-488,376-341,146-304,893-151,828-83,274
Operating profit (loss)-335,112-325,2842,590,33658,44546,600
Other non-operating income and expenses-154,429-237,4527,45033,780
Profit (loss) from continuing operations before tax-489,541-325,3072,597,78865,89580,380
Net profit (loss) from continuing operations-489,541-325,3072,597,78865,89580,380
Net profit (loss)-489,541-325,3072,597,78865,89580,380
Operating (rials)-10-3023554
Non-operating (rials)-50113
Arising from continuing operations-15-30---
سود (زیان) پایه هر سهم (ریال)-15 rials-30 rials236 rials6 rials7 rials
سود (زیان) خالص هر سهم (ریال)-15 rials-29 rials237 rials6 rials8 rials
Capital32,000,00011,000,00011,000,00011,000,00011,000,000

Reporting periods

36 periods are on file for this report, from the period ending 1392/02/31 to the period ending 1405/07/07.